Patents-Review.com
🔗 Permalink
Assignee profile:

LABORATOIRES SERONO S.A.

City:

Vaud

Country:

Switzerland

Published Applications:

10

Last publication date:

2010-02-04

Patent Grants:

9

Last grant date:

2011-11-15

Top Inventors for applications by LABORATOIRES SERONO S.A.

These are the the leading inventors for applications assigned to LABORATOIRES SERONO S.A.:

Recent patent applications by LABORATOIRES SERONO S.A.

LABORATOIRES SERONO S.A. based in Vaud, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2010-02-04
US20100029719A1
Chemistry; metallurgy

ARYLSULFONAMIDE DERIVATIVES AS C-JUN-N-TERMINAL KINASES (JNK'S) INHIBITORS

 #2 | 2009-11-26 ✅ Patent 8,058,305 granted on 2011-11-15
US20090292000A1
Chemistry; metallurgy

Pyrrolidine derivatives as prostaglandin modulators

 #3 | 2009-09-03 ✅ Patent 7,879,876 granted on 2011-02-01
US20090221575A1
Chemistry; metallurgy

Sulfonamide derivatives and use thereof for the modulation of metalloproteinases

 #4 | 2008-05-15 ✅ Patent 7,635,713 granted on 2009-12-22
US20080114051A1
Chemistry; metallurgy

Pyrrolidine derivatives as prostaglandin modulators

 #5 | 2008-05-08 ✅ Patent 7,479,575 granted on 2009-01-20
US20080108849A1
Chemistry; metallurgy

Method for preparing para-phenyl alkynyl benzaldehydes

 #6 | 2007-12-25 ✅ Patent 7,312,358 granted on 2007-12-25
US10399040
-

Pharmaceutically active sulfanilide derivatives

 #7 | 2007-08-09 ✅ Patent 7,465,755 granted on 2008-12-16
US20070185191A1
Chemistry; metallurgy

Hydrazide derivatives as prostaglandin receptors modulators

 #8 | 2005-10-06 ✅ Patent 7,479,486 granted on 2009-01-20
US20050222104A1
Chemistry; metallurgy

Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids

 #9 | 2005-08-11 ✅ Patent 7,335,680 granted on 2008-02-26
US20050176800A1
Chemistry; metallurgy

Pyrrolidine derivatives as prostaglandin modulators

 #10 | 2005-03-17 ✅ Patent 7,465,441 granted on 2008-12-16
US20050058623A1
Human necessities

Use of gp130 activators in diabetic neuropathy
AssigneeID:

217532 ⎘